Effect of Vojta Therapy on Covid-19 Respiratory Disease
Effect of Vojta Therapy in Respiratory Disease Caused by SARS-CoV-2. Randomized Controlled Pilot Study
1 other identifier
interventional
40
0 countries
N/A
Brief Summary
Vojta therapy is a physiotherapy intervention with scientific evidence in respiratory pathologies in children and proven in adults. In this pilot study with an RCT design, its effect in adult patients with respiratory pathology caused by the SARS-CoV-2 virus will be studied. The non-invasive and non-painful technique consists of applying tolerable pressure to specific areas of the patient's body. The objective is to activate, in a reflex way, the ventilatory physiology. It is compared with the conventional respiratory physiotherapy approach.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Sep 2021
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 28, 2021
CompletedFirst Posted
Study publicly available on registry
September 2, 2021
CompletedStudy Start
First participant enrolled
September 25, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 20, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
April 15, 2022
CompletedSeptember 2, 2021
August 1, 2021
3 months
August 28, 2021
August 30, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
SpO2
Oxygen saturation
3 weeks
Breathing frequency
frequency of respiratory cycles per minute
3 weeks
Stay time
Days of stay in the intermediate respiratory care unit
3 weeks
Study Arms (2)
Vojta Therapy
EXPERIMENTALReflex turn first phase: Patient positioned supine with legs flexed 30º-45º. The pectoral area is stimulated for five minutes on each side x 2 consecutive times. Total 20 minutes per session.
Control Group
ACTIVE COMPARATOR.Inspiratory techniques, mucociliary clearance techniques (expiratory). Use of inspiratory and expiratory incentives. Employment of mechanical assistants
Interventions
Eligibility Criteria
You may qualify if:
- respiratory disease by covid-19
You may not qualify if:
- patient older than 75 years
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Doctor
Study Record Dates
First Submitted
August 28, 2021
First Posted
September 2, 2021
Study Start
September 25, 2021
Primary Completion
December 20, 2021
Study Completion
April 15, 2022
Last Updated
September 2, 2021
Record last verified: 2021-08